These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26284871)

  • 1. Anaphylaxis incidence with rocuronium, succinylcholine, and atracurium: how risk communication can influence behavior.
    Dewachter P; Mouton-Faivre C
    Anesthesiology; 2015 Sep; 123(3):735-6. PubMed ID: 26284871
    [No Abstract]   [Full Text] [Related]  

  • 2. Anaphylaxis to neuromuscular-blocking drugs: all neuromuscular-blocking drugs are not the same.
    Mertes PM; Volcheck GW
    Anesthesiology; 2015 Jan; 122(1):5-7. PubMed ID: 25383569
    [No Abstract]   [Full Text] [Related]  

  • 3. Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium.
    Reddy JI; Cooke PJ; van Schalkwyk JM; Hannam JA; Fitzharris P; Mitchell SJ
    Anesthesiology; 2015 Jan; 122(1):39-45. PubMed ID: 25405395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Severe anaphylactic reactions after administration of rocuronium].
    Barthelet Y; Ryckwaert Y; Plasse C; Bonnet-Boyer MC; d'Athis F
    Ann Fr Anesth Reanim; 1999 Oct; 18(8):896-900. PubMed ID: 10575503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction.
    Pedersen AF; Green S; Rose MA
    Anaesth Intensive Care; 2012 Nov; 40(6):1053-5. PubMed ID: 23194216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 8. Is allergy to rocuronium a high probability cross-reaction with suxamethonium?
    Russell WJ; Lee C; Milne D
    Anaesth Intensive Care; 2003 Jun; 31(3):333. PubMed ID: 12879684
    [No Abstract]   [Full Text] [Related]  

  • 9. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative anaphylaxis to neuromuscular blocking agents: the incidence over 9 years at two tertiary hospitals in South Korea: A retrospective observational study.
    Cho YJ; Ju JW; Sim H; Lee JH; Hong DM; Kim TK; Min JJ; Song WJ; Kang HR; Cho SH; Jeon Y
    Eur J Anaesthesiol; 2016 May; 33(5):368-78. PubMed ID: 26575006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early skin and challenge testing after rocuronium anaphylaxis.
    Schulberg EM; Webb AR; Kolawole H
    Anaesth Intensive Care; 2016 May; 44(3):425-7. PubMed ID: 27246945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
    Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
    J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylaxis to muscle relaxants: an audit of ten years of allergy testing at the Royal Adelaide Hospital.
    Brereton A; Russell WJ
    Anaesth Intensive Care; 2012 Sep; 40(5):861-6. PubMed ID: 22934871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery from neuromuscular block after an intubation dose of cisatracurium and rocuronium in lumbar disc surgery.
    Hans P; Welter P; Dewandre PY; Brichant JF; Bonhomme V
    Acta Anaesthesiol Belg; 2004; 55(2):129-33. PubMed ID: 15264506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significantly prolonged neuromuscular blockade after a single dose of rocuronium: The importance of monitoring.
    Soares M; Esteves S
    Eur J Anaesthesiol; 2016 Sep; 33(9):693-4. PubMed ID: 27136491
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful management of rocuronium-induced anaphylaxis with sugammadex: A case report.
    Hung SK; Yeh CC; Ting PC; Chen CH; Kao MC
    J Int Med Res; 2022 Jul; 50(7):3000605221113913. PubMed ID: 35869623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anaphylaxis after rocuronium.
    Kierzek G; Audibert J; Pourriat JL
    Eur J Anaesthesiol; 2003 Feb; 20(2):169-70. PubMed ID: 12622507
    [No Abstract]   [Full Text] [Related]  

  • 18. Sugammadex and rocuronium-induced anaphylaxis.
    Takazawa T; Mitsuhata H; Mertes PM
    J Anesth; 2016 Apr; 30(2):290-7. PubMed ID: 26646837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cosmetic anaphylaxis?
    Russell WJ; George S
    J Clin Anesth; 2009 Sep; 21(6):461-3. PubMed ID: 19833284
    [No Abstract]   [Full Text] [Related]  

  • 20. Rocuronium: high risk for anaphylaxis?
    Rose M; Fisher M
    Br J Anaesth; 2001 May; 86(5):678-82. PubMed ID: 11575345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.